Detalhe da pesquisa
1.
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.
Lancet
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38795716
2.
A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries.
Br J Dermatol
; 190(3): 315-339, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36971254
3.
Treatment of Hidradenitis Suppurativa Evaluation Study (THESEUS): a prospective cohort study.
Br J Dermatol
; 190(3): 382-391, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37823414
4.
Global consensus process to establish a core dataset for hidradenitis suppurativa registries.
Br J Dermatol
; 190(4): 510-518, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37976235
5.
Electronic Patient-Reported Outcomes in Hidradenitis Suppurativa: Content Validity and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary, Hidradenitis Suppurativa Symptom Questionnaire, and Hidradenitis Suppurativa Quality of Life Questionnaire.
Dermatology
; 240(1): 65-76, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37820596
6.
The Global Hidradenitis Suppurativa Atlas (GHiSA) Methodology: Combining Global Proportions in a Pooled Analysis.
Dermatology
; 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38354718
7.
Effects of intraduodenal or intragastric administration of a bitter hop extract (Humulus lupulus L.), on upper gut motility, gut hormone secretion and energy intake in healthy-weight men.
Appetite
; 184: 106490, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36781111
8.
Single-cell analysis implicates TH17-to-TH2 cell plasticity in the pathogenesis of palmoplantar pustulosis.
J Allergy Clin Immunol
; 150(4): 882-893, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35568077
9.
New treatments and new assessment instruments for Hidradenitis suppurativa.
Exp Dermatol
; 31 Suppl 1: 33-39, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582833
10.
Pain measurement in painful skin conditions and rheumatoid arthritis randomized controlled trials: a scoping review to inform pain measurement in hidradenitis suppurativa.
Br J Dermatol
; 187(6): 846-854, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35962565
11.
Development and initial validation of the HS-IGA: a novel hidradenitis suppurativa-specific investigator global assessment for use in interventional trials.
Br J Dermatol
; 187(2): 203-210, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35599448
12.
The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study.
Br J Dermatol
; 187(4): 523-530, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35603888
13.
Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project.
Br J Dermatol
; 187(6): 927-935, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36056741
14.
Lipidomic and transcriptional analysis of the linoleoyl-omega-hydroxyceramide biosynthetic pathway in human psoriatic lesions.
J Lipid Res
; 62: 100094, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34171322
15.
What causes hidradenitis suppurativa ?-15 years after.
Exp Dermatol
; 29(12): 1154-1170, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33058306
16.
The epidemiology of hidradenitis suppurativa.
Br J Dermatol
; 183(6): 990-998, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32880911
17.
Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project.
J Am Acad Dermatol
; 82(2): 366-376, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31279015
18.
Addressing high placebo response rates in randomized clinical trials for hidradenitis suppurativa.
Br J Dermatol
; 190(3): 427-429, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37757841
19.
Inclusive and equitable language for skin colour in the British Journal of Dermatology: acknowledging our past and laying the foundations to move forward.
Br J Dermatol
; 190(5): 605-607, 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38477822
20.
Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study.
Br J Dermatol
; 190(5): 769-771, 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38305415